Dual Incretin Agonist 17mg — Verification Report
From AMC Essentials · Lot TZ17-0022ACC · Tested September 2025
VialTalk
Dual Incretin Agonist 17mg
AMC Essentials
Score
101.3
Grade
A++
Superlative
Lot TZ17-0022ACC
Tested September 2025
Report ID
af73d3ff
Test
Method
Result
Status
PurityFull credit
HPLC
99.9%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim · tested weight disclosed and verified
17 mg labeled · 20.08 mg tested
Full credit
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
Full credit
SterilityFull credit
USP <71> compendial
Screened
Full credit
Batch conformityPartial
Two-plus vials, per vial
Assessed
Partial
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/amc-essentials/coas/af73d3ff-d437-48f7-9f89-4a8109ea0a84